Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumor, Adult × Cetuximab × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 52 Carcinoma, Non-Small-Cell Lung 26 Squamous Cell Carcinoma of Head and Neck 25 Neoplasms 22 Head and Neck Neoplasms 22 Colonic Neoplasms 17 Neoplasm Metastasis 16 Rectal Neoplasms 10 Lung Neoplasms 9 Breast Neoplasms 9 Pancreatic Neoplasms 7 Carcinoma, Squamous Cell 5 Solid Tumors 4 Ovarian Neoplasms 4 Melanoma 4 Triple Negative Breast Neoplasms 3 Tongue Neoplasms 3 Stomach Neoplasms 3 Sarcoma 3 Salivary Gland Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Advanced Solid Tumor 3 Advanced Cancers 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Recurrence 2 Pharyngeal Neoplasms 2 Mouth Neoplasms 2 Laryngeal Diseases 2

Interventions

Cyclophosphamide 3 pembrolizumab 2 fludarabine 2 Radiotherapy 2 Paclitaxel 2 Ipilimumab 2 Interleukin-2 2 Carboplatin 2 spartalizumab 1 peposertib 1 niraparib 1 neotil 1 necitumumab 1 Valganciclovir 1 Tomography, X-Ray Computed 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1 Immune Checkpoint Inhibitors 1 GAT 1 Fluorodeoxyglucose F18 1 FCN-437c 1 Docetaxel 1 Cetuximab 1 Celecoxib 1 CS-1003 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡